BVI Introduces Innovative IOL Technology with New Belgium Facility Opening

BVI, a leading global provider of advanced surgical ophthalmology treatments, is proud to debut its newest and most cutting-edge facility in Liège, Belgium. The new expanse substantially increases BVI’s intraocular lens (IOL) production power, promising more profitable growth opportunities and solidifying its commitment to responsible environmental, social, and governance (ESG) principles.

BVI’s commitment to efficiency, sustainability, and compliance drove the design of the new facility, which was tailored to optimize delivery and increase production yield and efficiency. To reduce the carbon footprint, the company also implemented a range of environmental initiatives. With a focus on diminishing the facility’s environmental impact and maximizing value for clients, this new facility sets the bar for modern business practices.

The British Virgin Islands (BVI) proudly unveiled a new state-of-the-art integrated IOL research and development (R&D) and manufacturing facility, reaffirming its commitment to innovation and quality. This collaborative and cutting-edge installation enables the rapid creation of pioneering products for patient care, enabling seamless product development and production while speeding up the time to market.

BVI is making a bold move to further establish its leadership in the industry with this strategic investment. By investing in economic growth, technology, and innovation, BVI is positioned to make a significant contribution to its profitability and the economy. As BVI embarks on this journey, it is optimistic about the potential positive outcomes this investment will bring.

Shervin Korangy, BVI’s President and CEO applauded his team’s tremendous efforts in tripling the company’s IOL production capacity. He highlighted their dedication to excellence that enabled them to successfully deploy proprietary and precision molded optics meeting the highest quality standards.

Furthermore, the combination of patented, novel optical designs and the world-class manufacturing technology engenders an outstanding outcome. Korangy proudly stated that BVI’s IOL expertise continues to exceed his highest expectations.

About BVI

For over nine decades, BVI® has been a global leader in innovating and designing ophthalmic devices, striving to create solutions that advance eye surgery and permitting millions of patients to experience the joy of improved vision.

Combining our own trusted product lines – Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs) – with our expansive network of reliable and trusteddistributors, BVI partners with ophthalmic surgeons in more than 90 countries to help realize a world of better vision.

Leave a Comment